Lumida
/GANX
⌘K
Gain Therapeutics Inc

Gain Therapeutics Inc

GANX
$1.75USD+2.34%+0.04 today

MARKET CAP

76.4M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$2
$4
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023TREND
Sales, Adj.$164,994$132,640$55,180
YoY %-19.6%-58.4%
P / Sales334.5x290.3x854.8x
EV / Sales136.3x274.5x750.3x
Gross Profit, Adj.$164,994$132,640$55,180
YoY %-19.6%-58.4%
Margin %100.0%100.0%100.0%
EV / Gross Profit136.3x274.5x750.3x
EBITDA, Adj.$-13.8M$-17.7M$-22.2M
YoY %-28.3%-25.1%
Margin %-8370.4%-13359.7%-40176.8%
EV / EBITDA-1.6x-2.1x-1.9x
EBIT$-13.8M$-17.8M$-22.3M
YoY %-28.6%-25.1%
Margin %-8379.8%-13408.1%-40328.3%
EV / EBIT-1.6x-2.0x-1.9x
Net Income$-13.9M$-17.6M$-22.3M
YoY %-26.6%-26.6%
Net Margin-8418.9%-13262.0%-40354.3%
EPS (GAAP)-$1.37-$1.48-$1.71
YoY %-8.0%-15.5%